Targeting WEE1/AKT Restores p53-Dependent Natural Killer-Cell Activation to Induce Immune Checkpoint Blockade Responses in "Cold" Melanoma.

Overview of attention for article published in Cancer Immunology Research, April 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#49 of 1,594)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 7 news stories from 7 outlets.

Most skin cancer drugs that activate the immune system work by triggering immune cells, called T cells, to attack tumors, but…

Most skin cancer drugs that activate the immune system work by triggering immune cells, called T cells, to attack tumors, but…

UNIVERSITY PARK, Pa. — Most skin cancer drugs that activate the immune system work by triggering immune cells, called T cells…

Penn State UNIVERSITY PARK, Pa. — Most skin cancer drugs that activate the immune system work by triggering immune cells…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 3 additional news stories.